RedHill Biopharma reported $2.69M in EBIT for its fiscal quarter ending in June of 2023.


Ebit Change Date
Clal Biotechnology ILS -5438000 3.76M Dec/2022
Compugen USD -8429000 946K Jun/2025
Cronos Group USD -4384000 312K Jun/2025
RedHill Biopharma USD 2.69M 47.97M Jun/2023